Skip to content

Veracyte VCYT Raw materials

Raw materials at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Revvity logo
RevvityRVTY
Agilent Technologies logo
Agilent TechnologiesA
Idexx Laboratories logo
Idexx LaboratoriesIDXX
Danaher logo
DanaherDHR
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsAndSupplies.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's raw materials?
Veracyte (VCYT) reported raw materials of $21.42M in Q1 2026.
What is the long-term trend for Veracyte's raw materials?
Over 3 years (2021 to 2025), Veracyte's raw materials has grown at a 89.9% compound annual growth rate (CAGR), from $3M to $20.55M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.